Join
Live feed
·
PRReleasevia Quantisnow
Quantum Biopharma Ltd. logo

Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target

ByQuantisnow·Wall Street's wire, on your screen.
QNTM· Quantum Biopharma Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNTM (Quantum Biopharma Ltd.) and more on Quantisnow.